The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Amino-1-(3-hydroxy-2-methylphenyl)pyrrolo[3,2-b]quinoxaline-3-carboxamide ID: ALA5193896
PubChem CID: 168288812
Max Phase: Preclinical
Molecular Formula: C18H15N5O2
Molecular Weight: 333.35
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(O)cccc1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21
Standard InChI: InChI=1S/C18H15N5O2/c1-9-12(7-4-8-13(9)24)23-16(19)14(17(20)25)15-18(23)22-11-6-3-2-5-10(11)21-15/h2-8,24H,19H2,1H3,(H2,20,25)
Standard InChI Key: XFFSYXUNFMLWAI-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
-1.4604 -2.4704 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.6655 -1.8422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1146 -1.2280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2860 -0.4205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5707 -0.0075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5707 0.8184 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2860 1.2314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2860 2.0573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0014 2.4704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7167 2.0573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7167 1.2314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0014 0.8184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0014 -0.0075 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0427 -0.5598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.8511 -0.3879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4462 -0.9567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2897 -1.5988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2388 -0.7247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7167 -1.1810 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4341 0.0777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8367 0.6482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0441 0.4162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2931 -1.3144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0371 -1.8866 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3120 -1.7058 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
2 3 1 0
4 3 1 0
4 5 1 0
5 6 2 0
6 7 1 0
8 7 1 0
9 8 2 0
10 9 1 0
11 10 2 0
12 11 1 0
7 12 2 0
12 13 1 0
13 4 2 0
14 5 1 0
14 15 1 0
16 15 1 0
16 17 1 0
18 16 2 0
18 19 1 0
20 18 1 0
21 20 2 0
22 21 1 0
15 22 2 0
23 14 1 0
3 23 2 0
23 24 1 0
25 2 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 333.35Molecular Weight (Monoisotopic): 333.1226AlogP: 2.27#Rotatable Bonds: 2Polar Surface Area: 120.05Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.40CX Basic pKa: 1.00CX LogP: 3.00CX LogD: 3.00Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.52Np Likeness Score: -0.88
References 1. Szychowski J, Papp R, Dietrich E, Liu B, Vallée F, Leclaire ME, Fourtounis J, Martino G, Perryman AL, Pau V, Yin SY, Mader P, Roulston A, Truchon JF, Marshall CG, Diallo M, Duffy NM, Stocco R, Godbout C, Bonneau-Fortin A, Kryczka R, Bhaskaran V, Mao D, Orlicky S, Beaulieu P, Turcotte P, Kurinov I, Sicheri F, Mamane Y, Gallant M, Black WC.. (2022) Discovery of an Orally Bioavailable and Selective PKMYT1 Inhibitor, RP-6306., 65 (15.0): [PMID:35880755 ] [10.1021/acs.jmedchem.2c00552 ]